Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.9 EUR | -0.91% | -1.64% | -22.16% |
2023 | VIB Vermögen AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Price slide at Dic Asset continues after profit warning | DP |
Sales 2021 | 103M 111M 8.82B | Sales 2022 | 128M 137M 10.97B | Capitalization | 563M 603M 48.13B |
---|---|---|---|---|---|
Net income 2021 | 149M 160M 12.75B | Net income 2022 | 53M 56.8M 4.53B | EV / Sales 2021 | 18.8 x |
Net Debt 2021 | 680M 729M 58.21B | Net Debt 2022 | 671M 719M 57.39B | EV / Sales 2022 | 9.61 x |
P/E ratio 2021 |
8.43
x | P/E ratio 2022 |
10.7
x | Employees | 35 |
Yield 2021 |
1.87% | Yield 2022 |
-
| Free-Float | 31.86% |
1 day | -0.91% | ||
1 week | -1.64% | ||
Current month | -3.39% | ||
1 month | +1.50% | ||
3 months | -23.80% | ||
6 months | -4.08% | ||
Current year | -22.16% |
Managers | Title | Age | Since |
---|---|---|---|
Dirk Oehme
CEO | Chief Executive Officer | 49 | 21/03/22 |
Peter Njuguna
CTO | Chief Tech/Sci/R&D Officer | 51 | 31/12/13 |
Henry Karanja
CMP | Compliance Officer | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 05/02/23 | |
Jürgen Wittmann
BRD | Director/Board Member | 61 | 31/12/06 |
Gerhard Schmidt
CHM | Chairman | 67 | 12/04/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 17 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 10.82 | -1.64% | 1 088 |
26/04/24 | 11 | +0.92% | 4,647 |
25/04/24 | 10.9 | +0.18% | 4,488 |
24/04/24 | 10.88 | -0.91% | 10,255 |
23/04/24 | 10.98 | -0.18% | 4,774 |
Delayed Quote Xetra, April 29, 2024 at 08:11 am
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.16% | 388M | |
+36.16% | 27.94B | |
-14.03% | 26.97B | |
+21.76% | 26.95B | |
+2.86% | 25.32B | |
+44.49% | 22.58B | |
+2.02% | 19.59B | |
+5.67% | 19.52B | |
+28.54% | 16.23B | |
-14.67% | 14.98B |
- Stock Market
- Equities
- VIH1 Stock